240
Participants
Start Date
April 30, 2003
Study Completion Date
February 28, 2006
tolvaptan
New York
University of Pittsburgh Medical Center, Pittsburgh
The Arthur P. Noyes Research Foundation, Norristown
University of North Carolina, Div. of Cardiology, Chapel Hill
Medical College of Georgia, Augusta
University of Florida Gainesville, Gainesville
Charlotte Heart Group Research Ctr, Port Charlotte
Tennessee Center for Clinical Trials, Tullahoma
Baptist Clinical Research Ctr, Memphis
Ohio State University Medical Center, Columbus
University Hospitals of Cleveland, Cleveland
University of Iowa Hospital, Iowa City
Minneapolis VA Medical Center, Minneapolis
Mercury Street Medical, Butte
Northwestern University, Chicago
University of Chicago, Chicago
Washington University Ctr for Clinical Studies, St Louis
Aurora Denver Cardiology Association, Denver
University of Colorado Heath Science Center, Denver
VA Greater Los Angeles Health Care Ctr, Los Angeles
UCLA, Los Angeles
UCSF Medical Center, San Francisco
Northshore University Hospital, Great Neck
Collaborators (1)
Otsuka Pharmaceutical Co., Ltd.
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY